Our Services
Medical Information
Helpful Resources
Published on: 3/18/2026
Biologic therapies for inflammatory bowel disease (IBD) can fail for several reasons, including primary non-response, antibody-related loss of response, insufficient drug levels, or an incorrect diagnosis. The first step is careful re-evaluation, which typically includes infection screening and therapeutic drug monitoring to measure drug and antibody levels.
Next treatment options include:
Key monitoring goals include mucosal healing, symptom control, and normalized inflammatory markers. Urgent symptoms — such as severe abdominal pain, high fever, persistent bleeding, or signs of bowel obstruction — require immediate medical attention and may change the best next step.
Because biologic failure has many possible causes and next steps depend on your specific symptoms, history, and risk factors, understanding what's driving your situation is essential before making a treatment decision. A free, instant, online symptom check can help you clarify what may be going on, identify red flags, and prepare more informed questions for your gastroenterologist — so you can move forward with clarity instead of guesswork.
Reviewed for medical accuracy: 07/10/2026
If you're living with ulcerative colitis (UC) and biologics are no longer working—or never worked at all—you're not alone. Many patients eventually ask: What to do when no biologics work for UC?
Biologics have transformed UC treatment. They can reduce inflammation, prevent hospitalizations, and help people achieve remission. But they don't work for everyone. Some people never respond. Others respond at first, then lose benefit over time.
This can feel discouraging. But it does not mean you are out of options.
Let's break down why biologics may fail and what medical next steps are available.
Biologics target specific parts of the immune system that drive inflammation in UC. Common types include anti-TNF agents, anti-integrins, and anti-IL-12/23 therapies.
There are several reasons they may not work:
This means the medication never worked from the start. About 10–30% of patients may not respond to their first biologic.
Reasons include:
This happens when a drug worked initially but stops working later.
Common causes:
Sometimes the medication is right—but the dose isn't high enough. Blood testing can measure drug levels and antibodies to help guide adjustments.
Some people feel "okay" but still have silent inflammation on colonoscopy. Untreated inflammation can eventually cause flares.
Before moving on, your gastroenterologist will usually:
This step is critical. Sometimes the solution is as simple as adjusting the dose.
If you've tried one or more biologics without success, here are the evidence-based next steps.
If an anti-TNF drug failed, your doctor may switch you to:
Switching classes often works better than trying another drug in the same class—especially after primary non-response.
Small molecule medications are newer oral drugs that target inflammation differently than biologics.
Examples include:
Advantages:
These medications can be very effective for moderate to severe UC, especially in patients who have failed multiple biologics.
However, they require careful monitoring due to potential risks such as infections or blood clots in higher-risk individuals.
In some cases, doctors may:
Combination therapy can reduce antibody formation and improve durability of response.
If multiple approved treatments have failed, clinical trials may offer access to promising new therapies.
Benefits:
Ask your gastroenterologist whether trials are available in your area.
No one wants to hear the word "surgery." But for some patients, surgery is not a failure—it's a cure for colonic UC.
Ulcerative colitis affects only the colon. Removing the colon eliminates the disease.
Surgical options include:
Surgery is typically considered when:
Many patients report significantly improved quality of life after surgery. It's a serious decision, but for some, it's life-changing in a positive way.
Repeated treatment failure can be exhausting.
You may feel:
These reactions are normal. Chronic illness is hard.
Support options include:
Managing stress won't cure UC—but it can reduce flare triggers and improve overall well-being.
When biologics fail, close monitoring becomes even more important.
Your doctor may use:
The goal is mucosal healing, not just symptom control. Research shows that healing the lining of the colon reduces long-term complications.
If treatments repeatedly fail, doctors may reassess:
If you're struggling to understand whether your current symptoms match your UC diagnosis or might signal something different, using a free Ulcerative Colitis symptom checker can help you document your symptoms and prepare more specific questions for your gastroenterologist.
This is not a replacement for medical care—but it can help you prepare for a more informed discussion with your doctor.
Seek immediate medical care if you experience:
These could signal a severe flare or complication that requires urgent treatment.
If you're wondering what to do when no biologics work for UC, here's the honest answer:
You still have options.
Modern ulcerative colitis treatment includes:
Medicine is advancing quickly. New therapies continue to emerge, offering hope even after multiple treatment failures.
But this is not something to manage alone.
If your biologic isn't working:
And if symptoms are severe, worsening, or potentially life-threatening, seek urgent medical care immediately.
Ulcerative colitis can be stubborn. But resistant disease does not mean defeated disease. With the right strategy and specialist care, many patients eventually find a treatment path that works.
Make sure you speak to a doctor about any serious or worsening symptoms. Early action can prevent complications and protect your long-term health.
(References)
* Atallah, H., Singh, A., Patel, H., & Khan, N. (2023). Novel and emerging therapeutic strategies for ulcerative colitis refractory to biologics. *Expert Review of Clinical Immunology*, *19*(1), 79–88.
* Jharap, B., Dulai, P. S., & Sandborn, W. J. (2022). Treatment of Ulcerative Colitis Refractory to Biologic Agents. *Digestive Diseases and Sciences*, *67*(11), 5076–5085.
* Hagey, D. B., & Click, B. (2021). Management of Ulcerative Colitis Refractory to Biologics. *Gastroenterology Clinics of North America*, *50*(1), 145–156.
* Panchoo, K., Dassanayake, A., & Bressler, B. (2020). Advances in the Management of Biologic-Refractory Ulcerative Colitis. *Clinical and Translational Gastroenterology*, *11*(11), e00263.
* Afzali, A., & Cross, R. K. (2020). Therapeutic drug monitoring for biologics in inflammatory bowel disease. *Frontline Gastroenterology*, *11*(4), 303–309.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.